Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Hyperinsulinemia as a consequence of insulin resistance causes hyperandrogenemia in women. The objective was to review evidence for the converse situation, i.e. whether androgens adversely influence insulin action. Androgen excess could potentially contribute to the pathogenesis of insulin resistance in women with polycystic ovary syndrome (PCOS), metabolic syndrome/type 2 diabetes, and in obese peripubertal girls. An Entrez‐PubMed search was conducted to identify studies addressing the relationship of androgens with metabolic syndrome/type 2 diabetes in women. Studies reporting outcomes of androgen administration, interventions to reduce androgen effects in hyperandrogenemic women, and basic studies investigating androgen effects on insulin target tissues were reviewed. Multiple studies showed associations between serum testosterone and insulin resistance or metabolic syndrome/type 2 diabetes risk in women, but their cross‐sectional nature did not allow conclusions about causality. Androgen administration to healthy women was associated with development of insulin resistance. Intervention studies in women with hyperandrogenism were limited by small subject numbers and use of indirect methods for assessing insulin sensitivity. However, in three of the seven studies using euglycemic hyperinsulinemic clamps, reduction of androgen levels or blockade of androgen action improved insulin sensitivity. Testosterone administration to female rats caused skeletal muscle insulin resistance. Testosterone induced insulin resistance in adipocytes of women in vitro. In conclusion, the metabolic consequences of androgen excess in women have been under‐researched. Studies of long‐term interventions that lower androgen levels or block androgen effects in young women with hyperandrogenism are needed to determine whether these might protect against metabolic syndrome/type 2 diabetes in later life. Copyright © 2008 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045 · cited 1×
“respectively, develop metabolic syndrome [143,144].”
DUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Fisher, C. R., Graves, K. H., Parlow, A. F., & Simpson, E. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6965 · Cited by 867
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854 · cited 2×
“These phosphotyrosine residues act as docking sites for SH2 domain-containing proteins, including phosphatidylinositol (PI)3-kinase [102].”
BackgroundSalpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00545.x · Cited by 640 · cited 1×
“women [141] and on adipose tissue and skeletal muscle metabolism in ovariectomized mice [142] have been”
BackgroundOh, J.-Y., Barrett-Connor, E., Wedick, N. M., & Wingard, D. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.55 · Cited by 594
Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Abbott, D. H., Barnett, D. K., Bruns, C. M., & Dumesic, D. A. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi013 · Cited by 555 · cited 1×
“Metabolic consequences of androgen exposure in early life In animal models, prenatal [130,131] and neonatal [132,133] exposure to androgens resulted in increased adiposity, insulin resistance and alterations in adipose tissue lipolysis in adulthood, raising the possibility that androgens have a programming effect on a…”
BackgroundLabrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544 · cited 1×
“terone glucuronide, androstane-3α,17ß-diol glucuronide and androstane-3ß,17ß-diol glucuronide [112].”
BackgroundObesity and androgens: facts and perspectives
Pasquali, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.054 · Cited by 469
Godsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232003 · Cited by 417 · cited 1×
“While data on the effects of commonly used hormonal contraceptives on glucose homeostasis/insulin action are generally lacking [47,48], progesterone-only contraceptives with relatively high androgenicity have been associated with decreased insulin sensitivity in clamp studies [49] and an increased risk of type 2 diabe…”
BackgroundSingh, R., Artaza, J. N., Taylor, W. E., Braga, M., Yuan, X., Gonzalez-Cadavid, N. F., & Bhasin, S. (2006) · Endocrinology · doi:10.1210/en.2004-1649 · Cited by 369
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e392 · Cited by 337
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome
Ciaraldi, T. P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.2.577 · Cited by 336
Androgens, insulin resistance and vascular disease in men
Kapoor, D., Malkin, C. J., Channer, K. S., & Jones, T. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02299.x · Cited by 317
Androgen therapy in women: An Endocrine Society clinical practice guideline
Wierman, M. E., Basson, R., Davis, S. R., Khosla, S., Miller, K. K., Rosner, W., & Santoro, N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1121 · Cited by 301 · cited 2×
“significantly under-researched, as recently acknowledged by a task force of The Endocrine Society [148].”
BackgroundCorbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283
Self-citationFat Tissue: A Steroid Reservoir and Site of Steroid Metabolism
DESLYPERE, J. P., VERDONCK, L., & VERMEULEN, A. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-564 · Cited by 272
Testosterone concentrations in women and men with NIDDM
Andersson, B., Märin, P., Lissner, L., Vermeulen, A., & Björntorp, P. (1994) · Diabetes Care · doi:10.2337/diacare.17.5.405 · Cited by 268 · cited 1×
“Non-SHBG-bound testosterone was positively associated with fasting plasma insulin [28], and fasting plasma glucose [30], and negatively with insulin sensitivity measured by euglycemic hyperinsulinemic clamp [29].”
BackgroundLindstedt, G., Lundberg, P.-A., Lapidus, L., Lundgren, H., Bengtsson, C., & Björntorp, P. (1991) · Diabetes · doi:10.2337/diab.40.1.123 · Cited by 252
Gambineri, A., Patton, L., Vaccina, A., Cacciari, M., Morselli-Labate, A. M., Cavazza, C., Pagotto, U., & Pasquali, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2250 · Cited by 221 · cited 1×
“A recent study in overweight or obese women with PCOS treated for 12 months with flutamide showed that the improvement in insulin sensitivity increased with time, there being an additional benefit at 12 months compared with 6 months of treatment [94], suggesting that short duration of therapy may have influenced the o…”
ResultGambineri, A., Pelusi, C., Genghini, S., Morselli‐Labate, A. M., Cacciari, M., Pagotto, U., & Pasquali, R. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01973.x · Cited by 216 · cited 1×
“A recent study in overweight or obese women with PCOS treated for 12 months with flutamide showed that the improvement in insulin sensitivity increased with time, there being an additional benefit at 12 months compared with 6 months of treatment [94], suggesting that short duration of therapy may have influenced the o…”
ResultCorbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184 · cited 4×
“Downstream targets of PI3-kinase include Akt/protein kinase B (PKB) and atypical protein kinase C (aPKC) isoforms ζ/λ.”
BackgroundSelf-citationKjos, S. L. (1998) · JAMA · doi:10.1001/jama.280.6.533 · Cited by 174 · cited 1×
“While data on the effects of commonly used hormonal contraceptives on glucose homeostasis/insulin action are generally lacking [47,48], progesterone-only contraceptives with relatively high androgenicity have been associated with decreased insulin sensitivity in clamp studies [49] and an increased risk of type 2 diabe…”
BackgroundFalhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167 · cited 2×
“Affected adult women are hyperinsulinemic and are at increased risk of developing gestational diabetes mellitus [71].”
BackgroundSteroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
Lopez, L. M., Grimes, D. A., & Schulz, K. F. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006133.pub5 · Cited by 166
Charmandari, E., Weise, M., Bornstein, S. R., Eisenhofer, G., Keil, M. F., Chrousos, G. P., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8456 · Cited by 164 · cited 2×
“hyperplasia [70,71], hyperandrogenic women with the milder syndrome of non-classic congenital adrenal hyperplasia, not treated with glucocorticoids, also have reduced”
BackgroundInsulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency.
Speiser, P. W., Serrat, J., New, M. I., & Gertner, J. M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1464643 · Cited by 143
Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake
Campbell, S. E., & Febbraio, M. A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00184.2001 · Cited by 142
Increased Adiposity in Female Rhesus Monkeys Exposed to Androgen Excess During Early Gestation
Eisner, J. R., Dumesic, D. A., Kemnitz, J. W., Colman, R. J., & Abbott, D. H. (2003) · Obesity Research · doi:10.1038/oby.2003.42 · Cited by 133 · cited 1×
“Metabolic consequences of androgen exposure in early life In animal models, prenatal [130,131] and neonatal [132,133] exposure to androgens resulted in increased adiposity, insulin resistance and alterations in adipose tissue lipolysis in adulthood, raising the possibility that androgens have a programming effect on a…”
BackgroundDahlgren, E., Landin, K., Krotkiewski, M., Holm, G., & Janson, P. O. (1998) · Human Reproduction · doi:10.1093/humrep/13.10.2706 · Cited by 118
Nilsson, C., Niklasson, M., Eriksson, E., Björntorp, P., & Holmäng, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1353 · Cited by 103
Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women
Weinberg, M. E., Manson, J. E., Buring, J. E., Cook, N. R., Seely, E. W., Ridker, P. M., & Rexrode, K. M. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.017 · Cited by 101
Ibáñez, L., Ong, K., Ferrer, A., Amin, R., Dunger, D., & de Zegher, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022002 · Cited by 100
Reinecke, H., Bogdanski, J., Woltering, A., Breithardt, G. Ü., Assmann, G., Kerber, S., & von Eckardstein, A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02490-6 · Cited by 78
Alexanderson, C., Eriksson, E., Stener-Victorin, E., Lystig, T., Gabrielsson, B., Lönn, M., & Holmäng, A. (2007) · Endocrinology · doi:10.1210/en.2007-0305 · Cited by 69 · cited 1×
“Metabolic consequences of androgen exposure in early life In animal models, prenatal [130,131] and neonatal [132,133] exposure to androgens resulted in increased adiposity, insulin resistance and alterations in adipose tissue lipolysis in adulthood, raising the possibility that androgens have a programming effect on a…”
BackgroundZang, H., Rydén, M., Wåhlen, K., Dahlman-Wright, K., Arner, P., & Hirschberg, A. L. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.088 · Cited by 47
Research works printed but not linked: 110
- 10.1038/nature05485 · DOI · Paper page
- 10.1210/edrv-12-1-3 · DOI · Paper page
- 10.1210/er.18.6.774 · DOI · Paper page
- 10.1016/j.mehy.2005.09.057 · DOI
- 10.1111/j.1365-2796.1993.tb01016.x · DOI
- 10.1210/jc.2005-2665 · DOI
- 10.1042/cs1020151 · DOI · Paper page
- 10.1016/j.biochi.2004.11.012 · DOI
- 10.1001/jama.295.11.1288 · DOI · Paper page
- 10.1016/0960-0760(91)90310-2 · DOI · Paper page
- 10.1210/jc.2006-1990 · DOI · Paper page
- 10.1093/aje/154.6.489 · DOI · Paper page
- 10.1210/jcem.84.6.5824 · doi:10.1210/jcem.84.6.5824 · Paper page
- 10.1093/aje/155.5.437 · DOI · Paper page
- 10.1530/EJE-06-0702 · DOI
- 10.1042/cs0800199 · DOI · Paper page
- 10.1053/meta.2002.29997 · DOI · Paper page
- 10.1152/ajpendo.00339.2006 · DOI · Paper page
- 10.1093/aje/kwh250 · DOI · Paper page
- 10.1161/01.CIR.0000157697.54255.CE · DOI · Paper page
- 10.1210/jc.2006-1895 · DOI · Paper page
- 10.2337/diacare.19.12.1399 · DOI · Paper page
- 10.2337/diacare.23.7.912 · DOI · Paper page
- 10.2337/diacare.23.1.74 · DOI
- 10.1016/j.metabol.2005.06.011 · DOI
- 10.1210/jc.77.1.56 · DOI · Paper page
- 10.1016/S0015-0282(03)00347-9 · DOI
- 10.1210/jc.2005-1852 · DOI · Paper page
- 10.1210/jc.2006-2002 · DOI · Paper page
- 10.1210/jc.2007-0195 · DOI · Paper page
- Landon J, 1963, The effect of anabolic steroids on blood sugar and plasma insulin levels in man, Metabolism, 12, 924
- 10.1210/jc.79.1.265 · DOI · Paper page
- 10.1210/jc.83.12.4420 · DOI
- 10.1210/jc.81.6.2198 · DOI · Paper page
- 10.1097/00042192-200011000-00005 · DOI · Paper page
- 10.1016/j.fertnstert.2005.12.039 · DOI
- 10.1016/j.jsbmb.2004.02.003 · DOI
- 10.1002/14651858.CD006133.pub2 · DOI
- Shamma FN, 1995, The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions, Fertil Steril, 63, 767, 10.1016/S0015-0282(16)57479-2 · DOI
- 10.2337/dc06-2227 · DOI
- 10.1210/jc.83.6.2001 · DOI · Paper page
- 10.1210/jc.79.4.1158 · DOI · Paper page
- 10.1016/S0889-8545(05)70185-6 · DOI
- 10.1093/humrep/deh098 · DOI · Paper page
- 10.1210/jc.2004-2279 · DOI · Paper page
- 10.1210/jc.2006-1327 · DOI · Paper page
- 10.2337/diabetes.55.03.06.db05-0453 · DOI · Paper page
- 10.2337/diab.41.10.1257 · DOI · Paper page
- 10.1016/0026-0495(94)90013-2 · DOI
- 10.1016/j.metabol.2006.12.021 · DOI
- 10.1210/jcem-50-1-113 · DOI · Paper page
- 10.1210/jc.2005-1666 · DOI · Paper page
- 10.1210/jc.2004-1045 · DOI · Paper page
- 10.1210/jc.75.6.1421 · doi:10.1210/jc.75.6.1421 · Paper page
- 10.1159/000086363 · DOI · Paper page
- 10.1210/jcem-70-3-699 · DOI · Paper page
- 10.1016/0026-0495(95)90062-4 · DOI
- 10.1530/eje.0.1330718 · DOI · Paper page
- 10.1210/jc.81.3.952 · DOI · Paper page
- 10.1210/jcem.83.8.5041 · DOI · Paper page
- 10.1159/000070180 · DOI
- 10.1016/S0015-0282(16)56213-X · DOI
- 10.1093/humrep/14.4.893 · DOI
- 10.1016/S0015-0282(16)47716-2 · DOI
- 10.1016/S0015-0282(16)49211-3 · DOI · Paper page
- Lanzone A, 1990, Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist, Hum Reprod, 5, 143, 10.1093/oxfordjournals.humrep.a137058 · DOI · Paper page
- 10.1111/j.1365-2265.1990.tb00921.x · DOI
- Dale PO, 1992, Persistence of hyperinsulinemia in polycystic ovary syndrome after ovarian suppression by gonadotrophin‐releasing hormone agonist, Acta Endocrinol (Copenh), 126, 132
- 10.1007/BF03346907 · DOI
- 10.1016/S0015-0282(99)00275-7 · DOI
- 10.1080/09513590400004736 · DOI · Paper page
- 10.1159/000077827 · DOI
- 10.1007/BF03345529 · DOI
- 10.1210/jc.85.9.3251 · DOI · Paper page
- 10.1210/jc.87.6.2870 · DOI · Paper page
- 10.1016/S0015-0282(98)00006-5 · DOI
- 10.1210/jc.84.11.4278 · DOI
- 10.1111/j.1365-2265.1993.tb01771.x · DOI
- 10.1093/humrep/del466 · DOI · Paper page
- 10.1210/jc.87.2.716 · DOI
- 10.1016/S0079-6107(98)00056-X · DOI · Paper page
- 10.2337/diab.30.12.1000 · DOI · Paper page
- 10.1038/35055575 · DOI · Paper page
- 10.1152/ajpendo.00116.2005 · DOI · Paper page
- 10.1016/0022-4731(79)90514-4 · DOI
- 10.1111/j.1749-6632.1990.tb34293.x · DOI · Paper page
- 10.1172/JCI105588 · DOI · Paper page
- 10.1210/jcem-33-2-199 · DOI · Paper page
- 10.1016/0022-4731(83)90225-X · DOI
- 10.1210/jcem-59-5-949 · DOI · Paper page
- 10.1038/sj.ijo.0801886 · DOI
- 10.1210/jc.2003-030535 · DOI · Paper page
- 10.1677/joe.1.05762 · DOI · Paper page
- 10.1677/jme.1.01503 · DOI · Paper page
- 10.1046/j.1365-2362.1996.380603.x · DOI · Paper page
- Dieudonné MN, 1998, Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids, Am J Physiol, 274, C1645, 10.1152/ajpcell.1998.274.6.C1645 · DOI · Paper page
- 10.1055/s-2002-32144 · DOI · Paper page
- Dieudonne MN, 2000, Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site‐related specificities and possible involvement of insulin‐like growth factor 1 receptor and peroxisome proliferator‐activated receptor γ2, Endocrinol, 141, 649, 10.1210/endo.141.2.7293 · DOI · Paper page
- 10.1007/s00125-003-1324-0 · DOI · Paper page
- 10.1046/j.1463-1326.2002.00214.x · DOI · Paper page
- 10.1210/en.2006-0879 · DOI · Paper page
- Reiling BA, 1997, Effects of prenatal androgenization and lactation on adipose metabolism in finishing single‐calf heifers, J Anim Sci, 75, 1504, 10.2527/1997.7561504x · DOI
- 10.1016/j.lfs.2007.02.013 · DOI
- 10.1152/ajpendo.1990.259.4.E555 · DOI · Paper page
- Holmäng A, 1992, Effects of short‐term testosterone exposure on insulin sensitivity of muscles in female rats, Am J Physiol Endocrinol Metab, 262, E851, 10.1152/ajpendo.1992.262.6.E851 · DOI · Paper page
- 10.1046/j.1365-201X.2001.00801.x · DOI · Paper page
- Rincon J, 1996, Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment, Diabetes, 45, 615, 10.2337/diab.45.5.615 · DOI · Paper page
- 10.1074/jbc.M507339200 · DOI · Paper page
- 10.1210/en.2002-221123 · DOI · Paper page
- 10.1152/ajpendo.2001.281.4.E803 · DOI · Paper page
Cited by
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
Sex-Specific Differences in Lipid and Glucose Metabolism
Varlamov, O., Bethea, C. L., & Roberts, C. T. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00241 · Cited by 410
Hill, J. W., Elias, C. F., Fukuda, M., Williams, K. W., Berglund, E. D., Holland, W. L., Cho, Y.-R., Chuang, J.-C., Xu, Y., Choi, M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.002 · Cited by 391
Mauvais-Jarvis, F. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.10.002 · Cited by 335
Metadata
- Authors
- Corbould, A.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2008-07-10
- Volume
- 24
- Issue
- 7
- Pages
- 520-532
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W1984659394
- Cited by
- 144
- References
- 41
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.